264 related articles for article (PubMed ID: 20880840)
1. FoxOs function synergistically to promote glucose production.
Haeusler RA; Kaestner KH; Accili D
J Biol Chem; 2010 Nov; 285(46):35245-8. PubMed ID: 20880840
[TBL] [Abstract][Full Text] [Related]
2. Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.
Zhang K; Li L; Qi Y; Zhu X; Gan B; DePinho RA; Averitt T; Guo S
Endocrinology; 2012 Feb; 153(2):631-46. PubMed ID: 22147007
[TBL] [Abstract][Full Text] [Related]
3. Loss of Interdependent Binding by the FoxO1 and FoxA1/A2 Forkhead Transcription Factors Culminates in Perturbation of Active Chromatin Marks and Binding of Transcriptional Regulators at Insulin-sensitive Genes.
Yalley A; Schill D; Hatta M; Johnson N; Cirillo LA
J Biol Chem; 2016 Apr; 291(16):8848-61. PubMed ID: 26929406
[TBL] [Abstract][Full Text] [Related]
4. Forkhead box protein O1 (FoxO1) regulates hepatic serine protease inhibitor B1 (serpinB1) expression in a non-cell-autonomous fashion.
El Ouaamari A; O-Sullivan I; Shirakawa J; Basile G; Zhang W; Roger S; Thomou T; Xu S; Qiang G; Liew CW; Kulkarni RN; Unterman TG
J Biol Chem; 2019 Jan; 294(3):1059-1069. PubMed ID: 30459233
[TBL] [Abstract][Full Text] [Related]
5. Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.
Titchenell PM; Chu Q; Monks BR; Birnbaum MJ
Nat Commun; 2015 May; 6():7078. PubMed ID: 25963408
[TBL] [Abstract][Full Text] [Related]
6. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D
Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907
[TBL] [Abstract][Full Text] [Related]
7. Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.
Haeusler RA; Hartil K; Vaitheesvaran B; Arrieta-Cruz I; Knight CM; Cook JR; Kammoun HL; Febbraio MA; Gutierrez-Juarez R; Kurland IJ; Accili D
Nat Commun; 2014 Oct; 5():5190. PubMed ID: 25307742
[TBL] [Abstract][Full Text] [Related]
8. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
[TBL] [Abstract][Full Text] [Related]
9. FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization.
O-Sullivan I; Zhang W; Wasserman DH; Liew CW; Liu J; Paik J; DePinho RA; Stolz DB; Kahn CR; Schwartz MW; Unterman TG
Nat Commun; 2015 May; 6():7079. PubMed ID: 25963540
[TBL] [Abstract][Full Text] [Related]
10. Hepatic NPC1L1 overexpression ameliorates glucose metabolism in diabetic mice via suppression of gluconeogenesis.
Kurano M; Hara M; Satoh H; Tsukamoto K
Metabolism; 2015 May; 64(5):588-96. PubMed ID: 25660144
[TBL] [Abstract][Full Text] [Related]
11. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
12. Loss of FoxOs in muscle reveals sex-based differences in insulin sensitivity but mitigates diet-induced obesity.
Penniman CM; Suarez Beltran PA; Bhardwaj G; Junck TL; Jena J; Poro K; Hirshman MF; Goodyear LJ; O'Neill BT
Mol Metab; 2019 Dec; 30():203-220. PubMed ID: 31767172
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
[TBL] [Abstract][Full Text] [Related]
14. Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis.
Xiong X; Tao R; DePinho RA; Dong XC
PLoS One; 2013; 8(8):e74340. PubMed ID: 24015318
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice.
Nagashima T; Shigematsu N; Maruki R; Urano Y; Tanaka H; Shimaya A; Shimokawa T; Shibasaki M
Mol Pharmacol; 2010 Nov; 78(5):961-70. PubMed ID: 20736318
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miR-192-5p and upregulating transcription factor forkhead box O1.
Cai H; Jiang Z; Yang X; Lin J; Cai Q; Li X
Endocr J; 2020 Apr; 67(4):397-408. PubMed ID: 31875589
[TBL] [Abstract][Full Text] [Related]
17. FoxO1 deacetylation regulates thyroid hormone-induced transcription of key hepatic gluconeogenic genes.
Singh BK; Sinha RA; Zhou J; Xie SY; You SH; Gauthier K; Yen PM
J Biol Chem; 2013 Oct; 288(42):30365-30372. PubMed ID: 23995837
[TBL] [Abstract][Full Text] [Related]
18. Wnt signaling regulates hepatic metabolism.
Liu H; Fergusson MM; Wu JJ; Rovira II; Liu J; Gavrilova O; Lu T; Bao J; Han D; Sack MN; Finkel T
Sci Signal; 2011 Feb; 4(158):ra6. PubMed ID: 21285411
[TBL] [Abstract][Full Text] [Related]
19. Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice.
Nerurkar PV; Nishioka A; Eck PO; Johns LM; Volper E; Nerurkar VR
Br J Nutr; 2012 Jul; 108(2):218-228. PubMed ID: 22011624
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
